Lyra Direct SARS-COV-2 Assay (96/kt)

• RT-PCR for detecting human coronavirus SARS-CoV-2
• Uses direct lysis buffer to eliminate the need for extraction
• Results in less than 70 minutes
• Comes with 98 tests per kit .

The Quidel Lyra Direct SARS-COV-2 Assay is an accurate, real-time PCR used to qualitatively detect human coronavirus SARS-CoV-2.

No Extraction Needed: The Lyra Direct SARS-COV-2 Assay uses a direct lysis buffer that enables the detection of viral RNA directly from the sample, bypassing the traditional extraction step

Sample Types: Nasal, Nasopharyngeal (NP) or Oropharyngeal (OP) swab

For Use With: Applied Biosystems  7500 Fast Dx, Applied Biosystems 7500 Standard, Roche LightCycler  480 Instrument II, Roche cobas  z 480, Qiagen Rotor-Gene  Q, Bio-Rad CFX96 Touch, Thermo Fisher QuantStudio 7 Pro

FDA Disclaimers:
• This test is not FDA-cleared or approved.
• It has been authorized by the FDA under an Emergency Use Authorization for use by authorized laboratories.
• It has been authorized only for the detection of proteins from SARS-CoV-2 and not for any other viruses or pathogens.
• This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for the detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1) unless the authorization is terminated or revoked sooner.
 

WARNING: This product can expose you to chemicals known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.